Merkel Cell Carcinoma
Oncology·MeSH: Skin Neoplasms
Prevalence
30.0 / 100K
8 drugs in development·6 companies·19 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| ZYNYZ | MACROGENICS INC (MGNX) |
Phase 3(3)
Phase 2(2)
Phase 1(1)
| Drug | Company |
|---|---|
| ifx-hu2.0 | Tyra Biosciences, Inc. (TYRA) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| ifx-hu2.0 | TuHURA Biosciences, Inc./NV (HURA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Merkel Cell Carcinoma?
BioSniper tracks 8 drugs in development for Merkel Cell Carcinoma across 6 companies.
How many clinical trials target Merkel Cell Carcinoma?
There are 19 clinical trials targeting Merkel Cell Carcinoma tracked by BioSniper.
What is the prevalence of Merkel Cell Carcinoma?
The estimated prevalence of Merkel Cell Carcinoma is approximately 30.0 per 100,000 population.
Deep-dive into Merkel Cell Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis